Patents Assigned to Applied Cardiovascular Solutions, LLC
  • Methods, compositions, and devices for the occlusion of cavities and passageways
    Patent number: 11737761
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: August 29, 2023
    Assignees: Applied Cardiovascular Solutions, LLC, Board of Regents, The University of Texas System
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff
  • Methods, compositions, and devices for the occlusion of cavities and passageways
    Patent number: 11344313
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: May 31, 2022
    Assignees: APPLIED CARDIOVASCULAR SOLUTIONS, LLC, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff
  • Catheter assembly and systems and methods of using same
    Patent number: 11090056
    Abstract: Devices, systems, and methods for occluding cavities or passageways in a subject, such as the left atrial appendage of a subject's heart. The devices, systems, and methods can be used to decrease the rate of thromboembolic events associated with atrial fibrillation by occluding the left atrial appendage.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: August 17, 2021
    Assignee: APPLIED CARDIOVASCULAR SOLUTIONS, LLC
    Inventors: Rodney Paul Horton, Michael David Horton, Francisco Javier Otero
  • Methods, compositions, and devices for the occlusion of cavities and passageways
    Patent number: 10799246
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: October 13, 2020
    Assignees: Board or Regents, The University of Texas System, Applied Cardiovascular Solutions, LLC
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff
  • Methods, compositions, and devices for the occlusion of cavities and passageways
    Patent number: 10792044
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: October 6, 2020
    Assignees: Applied Cardiovascular Solutions, LLC, Board of Regents, The University of Texas System
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff
  • Compositions and devices for the occlusion of cavities and passageways
    Patent number: 10675038
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: June 9, 2020
    Assignees: Applied Cardiovascular Solutions, LLC, Board of Regents, The University of Texas System
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff
  • METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYS
    Publication number: 20140277070
    Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicants: Board of Regents, The University of Texas System, Applied Cardiovascular Solutions, LLC
    Inventors: F. Javier Otero, Joseph J. Beaman, Krishnendu Roy, Andrew Zimbroff